142 related articles for article (PubMed ID: 16458115)
1. siRNA targeting LMP1-induced apoptosis in EBV-positive lymphoma cells is associated with inhibition of telomerase activity and expression.
Mei YP; Zhu XF; Zhou JM; Huang H; Deng R; Zeng YX
Cancer Lett; 2006 Feb; 232(2):189-98. PubMed ID: 16458115
[TBL] [Abstract][Full Text] [Related]
2. Effect of inhibition of EBV-encoded latent membrane protein-1 by small interfering RNA on EBV-positive nasopharyngeal carcinoma cell growth.
Li G; Li XP; Peng Y; Liu X; Li XH
Di Yi Jun Yi Da Xue Xue Bao; 2004 Mar; 24(3):241-6. PubMed ID: 15041532
[TBL] [Abstract][Full Text] [Related]
3. Effect of EBV LMP1 targeted DNAzymes on cell proliferation and apoptosis.
Lu ZX; Ye M; Yan GR; Li Q; Tang M; Lee LM; Sun LQ; Cao Y
Cancer Gene Ther; 2005 Jul; 12(7):647-54. PubMed ID: 15803142
[TBL] [Abstract][Full Text] [Related]
4. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
[TBL] [Abstract][Full Text] [Related]
5. [Effect of Epstein-Barr virus latent membrane protein 1 (LMP1) on apoptosis of nasopharyngeal carcinoma cell line CNE1].
Chen Y; Chen XY
Ai Zheng; 2002 May; 21(5):498-503. PubMed ID: 12452040
[TBL] [Abstract][Full Text] [Related]
6. DNAzymes targeted to EBV-encoded latent membrane protein-1 induce apoptosis and enhance radiosensitivity in nasopharyngeal carcinoma.
Lu ZX; Ma XQ; Yang LF; Wang ZL; Zeng L; Li ZJ; Li XN; Tang M; Yi W; Gong JP; Sun LQ; Cao Y
Cancer Lett; 2008 Jul; 265(2):226-38. PubMed ID: 18353539
[TBL] [Abstract][Full Text] [Related]
7. Telomerase activation by Epstein-Barr virus latent membrane protein 1 is associated with c-Myc expression in human nasopharyngeal epithelial cells.
Yang J; Deng X; Deng L; Gu H; Fan W; Cao Y
J Exp Clin Cancer Res; 2004 Sep; 23(3):495-506. PubMed ID: 15595642
[TBL] [Abstract][Full Text] [Related]
8. Long-term suppression of telomerase expression in HeLa cell clones, transfected with an expression vector carrying siRNA targeting hTERT mRNA.
Kurvinen K; Syrjänen S; Johansson B
Int J Oncol; 2006 Jul; 29(1):279-88. PubMed ID: 16773210
[TBL] [Abstract][Full Text] [Related]
9. The heat-shock protein 90 inhibitor, geldanamycin, induces apoptotic cell death in Epstein-Barr virus-positive NK/T-cell lymphoma by Akt down-regulation.
Jeon YK; Park CH; Kim KY; Li YC; Kim J; Kim YA; Paik JH; Park BK; Kim CW; Kim YN
J Pathol; 2007 Oct; 213(2):170-9. PubMed ID: 17768706
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
Eur J Immunol; 2006 Mar; 36(3):593-602. PubMed ID: 16479544
[TBL] [Abstract][Full Text] [Related]
11. Expression of Epstein-Barr virus latent membrane protein 1 protects Jurkat T cells from apoptosis induced by serum deprivation.
Kawanishi M
Virology; 1997 Feb; 228(2):244-50. PubMed ID: 9123831
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells.
Liu MT; Chen YR; Chen SC; Hu CY; Lin CS; Chang YT; Wang WB; Chen JY
Oncogene; 2004 Apr; 23(14):2531-9. PubMed ID: 14716302
[TBL] [Abstract][Full Text] [Related]
13. HSV-tk/GCV gene therapy mediated by EBV-LMP1 for EBV-associated cancer.
Lifang Y; Min T; Midan A; Ya C
J Exp Clin Cancer Res; 2008 Sep; 27(1):42. PubMed ID: 18811956
[TBL] [Abstract][Full Text] [Related]
14. Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells.
Goldkorn A; Blackburn EH
Cancer Res; 2006 Jun; 66(11):5763-71. PubMed ID: 16740715
[TBL] [Abstract][Full Text] [Related]
15. [Effects of two LMP1 variants on resistance of CNE1 cell strain to TGF-beta1].
Huang H; Huang PC
Ai Zheng; 2003 Dec; 22(12):1254-9. PubMed ID: 14693046
[TBL] [Abstract][Full Text] [Related]
16. [Suppression of telomerase activity by plasmid-mediated RNA interference].
Li Y; Li M; Peng Y; Jiang Z; Li W; Li H
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):615-9. PubMed ID: 16856401
[TBL] [Abstract][Full Text] [Related]
17. [Inhibitory effect of RNAi targeting human telomerase reverse transcriptase against human hepatocellular carcinoma cells].
Li H; Wang XL; Yang Y; Zhang J; Wang GS; Jiang N; Chen GH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1323-6. PubMed ID: 18753050
[TBL] [Abstract][Full Text] [Related]
18. Antisense to Epstein Barr Virus-encoded LMP1 does not affect the transcription of viral and cellular proliferation-related genes, but induces phenotypic effects on EBV-transformed B lymphocytes.
Masciarelli S; Mattioli B; Galletti R; Samoggia P; Chichiarelli S; Mearini G; Mattia E
Oncogene; 2002 Jun; 21(26):4166-70. PubMed ID: 12037673
[TBL] [Abstract][Full Text] [Related]
19. [Construction and screening of a ribozyme targeting telomerase RNA and effects of telomerase ribozyme on proliferation and apoptosis of CNE-2Z cells].
Zhao YH; Chen XY; R Arrand J
Ai Zheng; 2004 Jan; 23(1):50-5. PubMed ID: 14720374
[TBL] [Abstract][Full Text] [Related]
20. Egr-1, a new downstream molecule of Epstein-Barr virus latent membrane protein 1.
Kim JH; Kim WS; Kang JH; Lim HY; Ko YH; Park C
FEBS Lett; 2007 Feb; 581(4):623-8. PubMed ID: 17257596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
